Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Operating Expenses (2010 - 2026)

Geron's (GERN) quarterly Operating Expenses came in at $70.0 million in Q2 2026, up 13.8% year-over-year from $61.5 million in Q2 2025, and up 35.41% quarter-over-quarter from $51.7 million in Q1 2026.

Analysis

Geron (GERN) Operating Expenses (2010 - 2026) Analysis & Trends

Geron has disclosed Operating Expenses across 17 years of filings, most recently posting $70.0 million for Q2 2026.

  • In Q2 2026, Operating Expenses rose 13.8% year-over-year to $70.0 million; the TTM figure through Jun 2026 stood at $256.3 million (up 5.98% YoY), while the FY2025 annual figure was $252.5 million, up 0.69% from the prior year.
  • Operating Expenses came in at $70.0 million for Q2 2026 at Geron, up from $51.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $73.6 million in Q4 2025 to a low of $28.0 million in Q2 2022.
  • Average Operating Expenses over 5 years is $53.2 million, with a median of $55.3 million recorded in 2023.
  • Year-over-year, Operating Expenses soared 85.32% in 2023 and retreated 12.43% in 2025.
  • Over 5 years, Operating Expenses stood at $42.1 million in 2022, then increased by 29.15% to $54.3 million in 2023, then rose by 24.44% to $67.6 million in 2024, then climbed by 8.83% to $73.6 million in 2025, then declined by 4.87% to $70.0 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $70.0 million in Q2 2026, $51.7 million in Q1 2026, and $73.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 367.83 Mn
10 Geron 914.60 Mn 613.75 Mn - 69.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.98 Mn
Mar 31, 2026 51.68 Mn
Dec 31, 2025 73.56 Mn
Sep 30, 2025 61.11 Mn
Jun 30, 2025 61.49 Mn
Mar 31, 2025 56.31 Mn
Dec 31, 2024 67.59 Mn
Sep 30, 2024 56.49 Mn
Jun 30, 2024 70.22 Mn
Mar 31, 2024 56.44 Mn
Dec 31, 2023 54.31 Mn
Sep 30, 2023 47.78 Mn
Jun 30, 2023 51.98 Mn
Mar 31, 2023 40.11 Mn
Dec 31, 2022 42.05 Mn
Sep 30, 2022 40.25 Mn
Jun 30, 2022 28.05 Mn
Mar 31, 2022 28.80 Mn
Dec 31, 2021 32.02 Mn
Sep 30, 2021 25.78 Mn